Layer by layer three-dimensional tissue epitaxy by cell-laden hydrogel droplets.

Center for Biomedical Engineering, Brigham and Women's Hospital, Harvard Medical School , Cambridge, MA, USA.
Tissue Engineering Part C Methods (Impact Factor: 4.64). 08/2009; 16(1):157-66. DOI: 10.1089/ten.TEC.2009.0179
Source: PubMed

ABSTRACT The ability to bioengineer three-dimensional (3D) tissues is a potentially powerful approach to treat diverse diseases such as cancer, loss of tissue function, or organ failure. Traditional tissue engineering methods, however, face challenges in fabricating 3D tissue constructs that resemble the native tissue microvasculature and microarchitectures. We have developed a bioprinter that can be used to print 3D patches of smooth muscle cells (5 mm x 5 mm x 81 microm) encapsulated within collagen. Current inkjet printing systems suffer from loss of cell viability and clogging. To overcome these limitations, we developed a system that uses mechanical valves to print high viscosity hydrogel precursors containing cells. The bioprinting platform that we developed enables (i) printing of multilayered 3D cell-laden hydrogel structures (16.2 microm thick per layer) with controlled spatial resolution (proximal axis: 18.0 +/- 7.0 microm and distal axis: 0.5 +/- 4.9 microm), (ii) high-throughput droplet generation (1 s per layer, 160 droplets/s), (iii) cell seeding uniformity (26 +/- 2 cells/mm(2) at 1 million cells/mL, 122 +/- 20 cells/mm(2) at 5 million cells/mL, and 216 +/- 38 cells/mm(2) at 10 million cells/mL), and (iv) long-term viability in culture (>90%, 14 days). This platform to print 3D tissue constructs may be beneficial for regenerative medicine applications by enabling the fabrication of printed replacement tissues.


Available from: Ali Khademhosseini, Jun 15, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: The motion, deformation, and stability of compound droplets in extensional flows are investigated numerically via a three-dimensional spectral boundary element method. We examine the droplet stability under the influences of the capillary number, the inner droplet size and the relative magnitude of the surface tension of the two interfaces composing the compound droplet. The influence of viscosity on the droplet deformation is also discussed. We conclude that a compound droplet with a larger inner droplet and/or smaller inner surface tension is less stable and cannot withstand strong flow. For moderate viscosity ratios, a compound droplet with a more viscous “shell” exhibits larger deformation at steady state. In addition, for an eccentric compound droplet, both the inner and outer droplets tend to migrate away from its original location due to the asymmetry of the problem. The initial location of the inner droplet also influences the droplet stability as well as the migration velocity of the compound droplet.
    Physics of Fluids 12/2012; 24(12). DOI:10.1063/1.4770294 · 2.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fabrication of three dimensional (3D) organoids with controlled microarchitectures has been shown to enhance tissue functionality. Bioprinting can be used to precisely position cells and cell-laden materials to generate controlled tissue architecture. Therefore, it represents an exciting alternative for organ fabrication. Despite the rapid progress in the field, the development of printing processes that can be used to fabricate macroscale tissue constructs from ECM-derived hydrogels has remained a challenge. Here we report a strategy for bioprinting of photolabile cell-laden methacrylated gelatin (GelMA) hydrogels. We bioprinted cell-laden GelMA at concentrations ranging from 7 to 15% with varying cell densities and found a direct correlation between printability and the hydrogel mechanical properties. Furthermore, encapsulated HepG2 cells preserved cell viability for at least eight days following the bioprinting process. In summary, this work presents a strategy for direct-write bioprinting of a cell-laden photolabile ECM-derived hydrogel, which may find widespread application for tissue engineering, organ printing and the development of 3D drug discovery platforms.
    Biofabrication 04/2014; 6(2):024105. DOI:10.1088/1758-5082/6/2/024105 · 4.30 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Derived from any somatic cell type and possessing unlimited self-renewal and differentiation potential, induced pluripotent stem cells (iPSCs) are poised to revolutionize stem cell biology and regenerative medicine research, bringing unprecedented opportunities for treating debilitating human diseases. To overcome the limitations associated with safety, efficiency, and scalability of traditional iPSC derivation, expansion, and differentiation protocols, biomaterials have recently been considered. Beyond addressing these limitations, the integration of biomaterials with existing iPSC culture platforms could offer additional opportunities to better probe the biology and control the behavior of iPSCs or their progeny in vitro and in vivo. Herein, we discuss the impact of biomaterials on the iPSC field, from derivation to tissue regeneration and modeling. Although still exploratory, we envision the emerging combination of biomaterials and iPSCs will be critical in the successful application of iPSCs and their progeny for research and clinical translation. © 2015 The Authors.
    The EMBO Journal 03/2015; 34(8). DOI:10.15252/embj.201490756 · 10.75 Impact Factor